Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2008-0736

2. Registrant Information.

Registrant Reference Number: Prosar case 1-15757002

Registrant Name (Full Legal Name no abbreviations): Scotts Canada Ltd.

Address: 2000 Argentia Road, Plaza 5, Suite 101

City: Mississauga

Prov / State: Ontario

Country: Canada

Postal Code: L5N2R7

3. Select the appropriate subform(s) for the incident.

Human

4. Date registrant was first informed of the incident.

05-FEB-08

5. Location of incident.

Country: CANADA

Prov / State: ONTARIO

6. Date incident was first observed.

Unknown

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

Active(s)

---

PMRA Registration No.       PMRA Submission No.       EPA Registration No.

Product Name: Killex (Non-Specific)

• Active Ingredient(s)
  • 2,4-D (PRESENT AS AMINE SALTS : DIMETHYLAMINE SALT, DIETHANOLAMINE SALT, OR OTHER AMINE SALTS)
  • DICAMBA (PRESENT AS ACID, AMINE SALT, ESTER, OR SODIUM SALT)
  • MECOPROP-P (PRESENT AS DIMETHYLAMINE SALT)

---

7. b) Type of formulation.

Application Information

8. Product was applied?

Yes

9. Application Rate.

Unknown

10. Site pesticide was applied to (select all that apply).

Site: Res. - Out Home / Rés - à l'ext.maison

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

The product was used by the reporter's wife for a month or more at some unknown time in the past to try and get rid of a poison ivy infestation outside the reporter's cottage. The specific type of Killex product is not known, but the active ingredients would include Dicamba, 2,4-D (unknown whether formulated as an acid, an amine salt or a low volatile ester), and MCPP (Mecoprop, unknown whether formulated as a potassium salt, an acid, an amine salt, a D-isomer, etc.

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform II: Human Incident Report (A separate form for each person affected)

1. Source of Report.

Other

2. Demographic information of data subject

Sex: Female

Age: >19 <=64 yrs / >19 <=64 ans

3. List all symptoms, using the selections below.

System

• Nervous and Muscular Systems
  • Symptom - Other
  • Specify - ALS - Amyotrophic Lateral Sclerosis

4. How long did the symptoms last?

Anticip. permanent/Permanence anticipée

5. Was medical treatment provided? Provide details in question 13.

Yes

6. a) Was the person hospitalized?

Unknown

6. b) For how long?

7. Exposure scenario

Non-occupational

8. How did exposure occur? (Select all that apply)

Other

9. If the exposure occured during application or re-entry, what protective clothing was worn? (select all that apply)

Unknown

10. Route(s) of exposure.

Unknown

11. What was the length of exposure?

>1 mo <= 6 mos / > 1 mois < = 6 mois

12. Time between exposure and onset of symptoms.

Unknown / Inconnu

13. Provide any additional details about the incident (eg. description of the frequency and severity of the symptoms, type of medical treatment, results from medical tests, outcome of the incident, amount of pesticide exposed to, etc.)

(number) The reporter e-mailed the company's website on or about 2/5/08 to report that his (age) year old wife had been using a Killex product for a month or more at some unknown time in the past to try and get rid of a poison ivy infestation outside the reporter's cottage. The reporter did not know the specific type of Killex product his wife used, but the active ingredients would include Dicamba, 2,4-D, and MCPP. The reporter did not explain the specific manner in which the wife was exposed (during application, etc.). The reporter wife was recently diagnosed with ALS (Amyotrophic Lateral Sclerosis) and is under the care of a medical team. The reporter was requesting information regarding any research done on the safety of the product as well as any research on an association between product use and neurological development. A follow-up e-mail was sent to the reporter but no subsequent contact has been received.

To be determined by Registrant

14. Severity classification.

Major

15. Provide supplemental information here.